Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma
- PMID: 11557778
- DOI: 10.1038/modpathol.3880399
Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma
Abstract
Invasive micropapillary carcinoma (IMPCa) of breast is histologically characterized by growth of cohesive tumor cell clusters within prominent clear spaces resembling dilated angiolymphatic vessels. In this study, eighty three breast carcinomas with IMPCa differentiation were identified by review of the invasive carcinoma cases in our institution and correlated retrospectively with standard clinicopathologic parameters and survival status relative to a control series of cases (mean follow up 7 years). IMPCa growth pattern was present in 6% of all breast carcinomas; it was generally a focal component in otherwise typical invasive ductal carcinoma. It comprised more than 80% of the total neoplasm in only 10 cases (12%), 50-80% of the neoplasm in 7 cases (8%), 20-50% of the neoplasm in 22 cases (26%) and less than 20% in 44 cases (53%). The mean tumor size was 4 cm, 22% invaded skin, and 58% were poorly differentiated, but 71% were ER positive. Axillary node metastases were present in 77% of cases, were typically multiple (51% had three or more positive), and usually contained an IMPCa component (81% of the cases). There was no significant difference in node status, ER status, size, tumor grade, or peritumoral angiolymphatic invasion between tumors with predominant (more than 50%) v/s focal IMPCa components. In both groups 46% of the patients died from their disease (mean interval to death = 36m). Skin involvement and nodal status were the only parameters which predicted poor survival (P =.01). The outcome of patients with IMPCa did not differ significantly from infiltrating ductal carcinomas of similar node status. In conclusion, our results suggest that IMPCa growth pattern may be a manifestation of aggressive behavior, as shown by frequent skin invasion and extensive nodal involvement. However, clinicopathologic features and outcome of IMPCa are not strongly dependent on the relative amount of micropapillary component.
Similar articles
-
Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity.Hum Pathol. 2001 Jun;32(6):583-9. doi: 10.1053/hupa.2001.24988. Hum Pathol. 2001. PMID: 11431712
-
Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma.Am J Surg Pathol. 2010 Nov;34(11):1637-46. doi: 10.1097/PAS.0b013e3181f5539c. Am J Surg Pathol. 2010. PMID: 20975342
-
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.Breast Cancer Res Treat. 2008 Oct;111(3):541-7. doi: 10.1007/s10549-007-9809-z. Epub 2007 Nov 18. Breast Cancer Res Treat. 2008. PMID: 18026874
-
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.APMIS Suppl. 2003;(108):1-67. APMIS Suppl. 2003. PMID: 12874968 Review.
-
Carcinomas with micropapillary morphology: clinical significance and current concepts.Adv Anat Pathol. 2004 Nov;11(6):297-303. doi: 10.1097/01.pap.0000138142.26882.fe. Adv Anat Pathol. 2004. PMID: 15505530 Review.
Cited by
-
Advances in invasive micropapillary carcinoma of the breast research: A review.Medicine (Baltimore). 2024 Jan 5;103(1):e36631. doi: 10.1097/MD.0000000000036631. Medicine (Baltimore). 2024. PMID: 38181281 Free PMC article. Review.
-
Nomogram predicting overall prognosis for invasive micropapillary carcinoma of the breast: a SEER-based population study.BMJ Open. 2023 Aug 7;13(8):e072632. doi: 10.1136/bmjopen-2023-072632. BMJ Open. 2023. PMID: 37550031 Free PMC article.
-
Authentication of a survival nomogram for non-invasive micropapillary breast cancer.Front Oncol. 2023 Jul 12;13:1156015. doi: 10.3389/fonc.2023.1156015. eCollection 2023. Front Oncol. 2023. PMID: 37503326 Free PMC article.
-
A web-based novel model for predicting prognostic value in patients with invasive micropapillary carcinoma in breast cancer: a real-world data retrospective cohort study.Updates Surg. 2023 Oct;75(7):1997-2004. doi: 10.1007/s13304-023-01530-7. Epub 2023 May 24. Updates Surg. 2023. PMID: 37222906
-
Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast.BMJ Open. 2023 Feb 21;13(2):e065312. doi: 10.1136/bmjopen-2022-065312. BMJ Open. 2023. PMID: 36810178 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical